Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 3:9:732036.
doi: 10.3389/fcell.2021.732036. eCollection 2021.

Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications

Affiliations
Review

Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications

Di Chen et al. Front Cell Dev Biol. .

Abstract

Gastric cancer (GC) is one of the most lethal malignancies worldwide. However, the molecular mechanisms underlying gastric carcinogenesis remain largely unknown. Over the past decades, advances in RNA-sequencing techniques have greatly facilitated the identification of various non-coding RNAs (ncRNAs) in cancer cells, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs). Accumulating evidence has revealed that ncRNAs are essential regulators in GC occurrence and development. However, ncRNAs represent an emerging field of cancer research, and their complex functionality remains to be clarified. Considering the lack of viable biomarkers and therapeutic targets in GC, further studies should focus on elucidating the intricate relationships between ncRNAs and GC, which can be translated into clinical practice. In this review, we summarize recent research progress on how ncRNAs modulate the malignant hallmarks of GC, especially in tumor immune escape, drug resistance, and stemness. We also discuss the promising applications of ncRNAs as diagnostic biomarkers and therapeutic targets in GC, aiming to validate their practical value for clinical treatment.

Keywords: biological functions; biomarker; gastric cancer; non-coding RNAs; targeted therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Biogenesis and function of miRNA, lncRNA and circRNA. (A) MiRNAs are processed from stem-loop structures of longer RNA transcripts. Mature miRNAs are loaded into the RNA-induced silencing complex (RISC) to modulate target mRNA expression by degradation or translational repression. (B) Most lncRNAs transcribed by RNA polymerase II are polyadenylated at 3′, 5′ capped and spliced. LncRNAs act as decoys or sponges for transcription factors or miRNAs and serve as regulatory molecules in epigenetic gene regulation, splicing, mRNA stability, and translation. (C) The majority of circRNAs are formed by back-splicing of precursor mRNAs (pre-mRNAs). CircRNAs exert their function via various mechanisms, including miRNA sponging, translation into proteins, interacting with proteins, and regulating their function.
FIGURE 2
FIGURE 2
The role of ncRNAs in regulating the malignant hallmarks of GC. Selected examples of ncRNAs and their molecular mechanisms in modulating the malignant hallmarks of GC, including cell proliferation, resistance to cell death, invasion and metastasis, angiogenesis, tumor-promoting inflammation, tumor immune escape, stemness, and therapy resistance.

References

    1. Abe S., Matsuzaki J., Sudo K., Oda I., Katai H., Kato K., et al. (2021). A Novel Combination of Serum microRNAs for the Detection of Early Gastric Cancer. Gastric Cancer 24, 835–843. 10.1007/s10120-021-01161-0 - DOI - PMC - PubMed
    1. Amaravadi R. K., Kimmelman A. C., Debnath J. (2019). Targeting Autophagy in Cancer: Recent Advances and Future Directions. Cancer Discov. 9 (9), 1167–1181. 10.1158/2159-8290.CD-19-0292 - DOI - PMC - PubMed
    1. An Y., Zhang Z., Shang Y., Jiang X., Dong J., Yu P., et al. (2015). miR-23b-3p Regulates the Chemoresistance of Gastric Cancer Cells by Targeting ATG12 and HMGB2. Cell Death Dis 6–e1766. 10.1038/cddis.2015.123 - DOI - PMC - PubMed
    1. Anastasiadou E., Jacob L. S., Slack F. J. (2018). Non-coding RNA Networks in Cancer. Nat. Rev. Cancer 18 (1), 5–18. 10.1038/nrc.2017.99 - DOI - PMC - PubMed
    1. Anfossi S., Babayan A., Pantel K., Calin G. A. (2018). Clinical Utility of Circulating Non-coding RNAs - an Update. Nat. Rev. Clin. Oncol. 15 (9), 541–563. 10.1038/s41571-018-0035-x - DOI - PubMed